Disease-Modifying Therapy After Natalizumab Discontinuation in Patients with Relapsing Multiple Sclerosis.
- Published in:
- Neurology Alert, 2023, v. 42, n. 12, p. 1
- Publication type:
- Article
Works matching IS 07414234 AND DT 2023 AND VI 42 AND IP 12
Results: 5
1
2
Treatment of Psychotic Symptoms in Alzheimer's Disease.
- Published in:
- Neurology Alert, 2023, v. 42, n. 12, p. 1
- Publication type:
- Article
3
Antidepressants for Chronic Pain: Do They Work?
- Published in:
- Neurology Alert, 2023, v. 42, n. 12, p. 1
- Publication type:
- Article
4
Celery Seed-Derived Compound: A Legitimate Neuroprotectant for Acute Ischemic Stroke?
- Published in:
- Neurology Alert, 2023, v. 42, n. 12, p. 1
- Publication type:
- Article
5
Brain Atrophy and Type 1 Diabetes.
- Published in:
- Neurology Alert, 2023, v. 42, n. 12, p. 1
- Publication type:
- Article